Home Actueel Nieuws uit ons netwerk Leading Dutch alliance in biochip development

18 april 2019

Leading Dutch alliance in biochip development

As of April 15, 2019, Qurin Diagnostics B.V. and Lionix International B.V. have acquired Surfix B.V. As a supplier of custom-made nanocoatings, the capabilities of Surfix are highly complementary to the products and services offered by Qurin and LioniX International. The companies are already working together closely on early cancer detection and have realized a sensitive biochip, bringing together their respective complementary technologies for this purpose. This acquisition strengthens their relationship and mutual commitment towards bringing this technology to the global biomedical market.

Read the complete press release


Terug naar het overzicht

Auteur:
Petra Wicherink
LioniX International BV

Publicatie over partner(s):


Tags

Health Valley Partners